Genomma Opts for FRN
Given strong demand for floating-rate bonds as yields rise, Genomma Lab has opted for a floating-rate tranche over a 10-year fixed portion in its MXP2bn ($154m) domestic...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.